{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:50:41Z","timestamp":1777636241405,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017332","name":"Rafsanjan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.advms.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T07:28:32Z","timestamp":1680161312000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model"],"prefix":"10.1016","volume":"68","author":[{"given":"Raziyeh","family":"Zandvakili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Basirjafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Zainodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Taghipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheila","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-1321","authenticated-orcid":false,"given":"Tayyebeh","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1562-3257","authenticated-orcid":false,"given":"Sepehr","family":"Safdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-6055","authenticated-orcid":false,"given":"Mahsa","family":"Gheitasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ayoobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-0602","authenticated-orcid":false,"given":"Abdollah","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2023.03.002_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.advms.2023.03.002_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/CCO.0000000000000878","article-title":"Immunotherapy and breast cancer: an overview","volume":"34","author":"Mezni","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.advms.2023.03.002_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fendo.2017.00270","article-title":"Breast cancer vaccines: new insights","volume":"8","author":"Benedetti","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.advms.2023.03.002_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.advms.2023.03.002_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaci.2009.11.019","article-title":"Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis","volume":"125","author":"Novak","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trecan.2017.12.007","article-title":"Re-emergence of dendritic cell vaccines for cancer treatment","volume":"4","author":"Saxena","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.advms.2023.03.002_bib8","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-03-3505","article-title":"Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma","volume":"64","author":"Yu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.advms.2023.03.002_bib9","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/1078-0432.CCR-13-1185","article-title":"A\u00a0dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to BedsideHOCl-oxidized lysate-pulsed DC elicits potent TH1 responses","volume":"19","author":"Chiang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.advms.2023.03.002_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00262-002-0338-7","article-title":"Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response","volume":"52","author":"Vegh","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.advms.2023.03.002_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc.2016.16","article-title":"Vaccines for established cancer: overcoming the challenges posed by immune evasion","volume":"16","author":"van der Burg","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.advms.2023.03.002_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.advms.2023.03.002_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.advms.2023.03.002_bib14","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1084\/jem.186.11.1819","article-title":"In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas","volume":"186","author":"Reis e Sousa","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.advms.2023.03.002_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1189\/jlb.1002483","article-title":"Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes","volume":"73","author":"Harizi","year":"2003","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.advms.2023.03.002_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-1711.2004.01213.x","article-title":"Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2","volume":"82","author":"Fogel-Petrovic","year":"2004","journal-title":"I\u00a0Immunol Cell Biol"},{"key":"10.1016\/j.advms.2023.03.002_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1054\/plef.2002.0383","article-title":"Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells","volume":"66","author":"Harizi","year":"2002","journal-title":"rostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.advms.2023.03.002_bib19","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.168.5.2255","article-title":"Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions","volume":"168","author":"Harizi","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.2001.1785","article-title":"Dendritic cells issued in vitro from bone marrow produce PGE2 that contributes to the immunomodulation induced by antigen-presenting cells","volume":"209","author":"Harizi","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.181.2.775","article-title":"Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production","volume":"181","author":"van der Pouw Kraan","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.advms.2023.03.002_bib22","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/blood-2009-12-258038","article-title":"PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells","volume":"116","author":"Muthuswamy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.advms.2023.03.002_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11373-007-9173-3","article-title":"Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib","volume":"14","author":"Kardosh","year":"2007","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.advms.2023.03.002_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.taap.2007.04.007","article-title":"Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells","volume":"222","author":"Hsiao","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.advms.2023.03.002_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.advms.2023.03.002_bib26","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.18632\/oncotarget.3581","article-title":"MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer","volume":"6","author":"Olesch","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.advms.2023.03.002_bib27","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.179.3.1497","article-title":"Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva","volume":"179","author":"S\u00e1-Nunes","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib28","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.4049\/jimmunol.161.6.2804","article-title":"Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation","volume":"161","author":"Kali\u0144ski","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib29","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.4049\/jimmunol.156.5.1722","article-title":"Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells","volume":"156","author":"Hilkens","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib30","doi-asserted-by":"crossref","first-page":"115254","DOI":"10.18632\/oncotarget.23250","article-title":"Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E(2) and down-regulating the Wnt pathway activity","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.advms.2023.03.002_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1200\/JCO.18.00636","article-title":"Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: exploratory Analysis of the REMAGUS02 trial","volume":"37","author":"Hamy","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.advms.2023.03.002_bib32","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3390\/curroncol29090482","article-title":"The efficacy and safety of celecoxib in addition to standard cancer therapy: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Ye","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.advms.2023.03.002_bib33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1523-5378.2010.00796.x","article-title":"Short-term therapy with celecoxib and lansoprazole modulates Th1\/Th2 immune response in human gastric mucosa","volume":"15","author":"Larussa","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.advms.2023.03.002_bib34","first-page":"1","article-title":"Celecoxib upregulates ULBP-1 expression in lung cancer cells via the JNK\/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity","volume":"20","author":"Kim","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.advms.2023.03.002_bib35","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/cam4.1487","article-title":"Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats","volume":"7","author":"Chu","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.advms.2023.03.002_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1074374","article-title":"Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity","volume":"5","author":"Li","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.advms.2023.03.002_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1054\/plef.2002.0383","article-title":"Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells","volume":"66","author":"Harizi","year":"2002","journal-title":"Prostagl Leukot Essent Fat Acids"},{"key":"10.1016\/j.advms.2023.03.002_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.advms.2022.02.006","article-title":"Inhibition of apelin\/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer","volume":"67","author":"Masoumi","year":"2022","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.advms.2023.03.002_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00210-010-0586-6","article-title":"Celecoxib induces heme oxygenase-1 expression in macrophages and vascular smooth muscle cells via ROS-dependent signaling pathway","volume":"383","author":"Wang","year":"2011","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.advms.2023.03.002_bib40","first-page":"694","article-title":"COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes\/macrophages","volume":"65","author":"Voloshyna","year":"2017","journal-title":"J\u00a0Invest Med"},{"key":"10.1016\/j.advms.2023.03.002_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/08923973.2016.1147578","article-title":"Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line","volume":"38","author":"Kondreddy","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.advms.2023.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099285","article-title":"Celecoxib sensitizes Staphylococcus aureus to antibiotics in macrophages by modulating SIRT1","volume":"9","author":"Annamanedi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.03.002_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2016.12.012","article-title":"CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice","volume":"246","author":"Jadidi-Niaragh","year":"2017","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.advms.2023.03.002_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ijms21010170","article-title":"Single cell mass cytometry revealed the immunomodulatory effect of cisplatin via downregulation of splenic CD44+, IL-17a+ MDSCs and promotion of circulating IFN-\u03b3+ myeloid cells in the 4T1 metastatic breast cancer model","volume":"21","author":"Balog","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2023.03.002_bib45","article-title":"Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy","volume":"29","author":"Masjedi","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.advms.2023.03.002_bib46","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.31557\/APJCP.2022.23.6.1847","article-title":"Cimetidine and ibuprofen modulate T cell responses in a mouse model of breast cancer","volume":"23","author":"Oladpour","year":"2022","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.advms.2023.03.002_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.micpath.2018.01.040","article-title":"T\u00a0cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection","volume":"116","author":"Jafarzadeh","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.advms.2023.03.002_bib48","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.7010.1","article-title":"Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells","volume":"4","author":"Ma","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.advms.2023.03.002_bib49","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.advms.2023.03.002_bib50","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/ijc.21616","article-title":"Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer","volume":"118","author":"Hahn","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.advms.2023.03.002_bib51","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1245\/s10434-020-09464-9","article-title":"Phase II trial of adjuvant dendritic cell vaccine in combination with celecoxib, interferon-\u03b1, and rintatolimod in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases","volume":"28","author":"Ramanathan","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.advms.2023.03.002_bib52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CEJ.0000000000000083","article-title":"Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats","volume":"23","author":"Kiskov\u00e1","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.advms.2023.03.002_bib53","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.4049\/jimmunol.177.4.2391","article-title":"Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of Ido","volume":"177","author":"Basu","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2023.03.002_bib54","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/ijc.22720","article-title":"Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma","volume":"121","author":"Irie","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.advms.2023.03.002_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3727\/096504013X13685487925176","article-title":"Enhancement of antitumor activity by combination of tumor lysate-pulsed dendritic cells and celecoxib in a rat glioma model","volume":"20","author":"Zhang","year":"2013","journal-title":"Oncol Res"},{"key":"10.1016\/j.advms.2023.03.002_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1074374","article-title":"Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity","volume":"5","author":"Li","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.advms.2023.03.002_bib57","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.intimp.2018.12.039","article-title":"Maturation of dendritic cells by maitake \u03b1-glucan enhances anti-cancer effect of dendritic cell vaccination","volume":"67","author":"Masuda","year":"2019","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.advms.2023.03.002_bib58","article-title":"Specific medicinal plant polysaccharides effectively enhance the potency of a DC-based vaccine against mouse mammary tumor metastasis","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.03.002_bib59","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/j.vaccine.2018.06.016","article-title":"Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines","volume":"36","author":"Dobrovolskien\u0117","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.advms.2023.03.002_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00262-018-2238-5","article-title":"An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells","volume":"68","author":"Tomasicchio","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.advms.2023.03.002_bib61","first-page":"5853","article-title":"Interleukin 18 gene transfer expands the repertoire of antitumor Th1-type immunity elicited by dendritic cell-based vaccines in association with enhanced therapeutic efficacy","volume":"62","author":"Tatsumi","year":"2002","journal-title":"Cancer Res"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:31Z","timestamp":1761824671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112623000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1896112623000111"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.03.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}